Skip to main content


Log in

Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options – a Retrospective Analysis

  • Original Research
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript



Nijmegen Breakage Syndrome (NBS) is a rare inherited condition, characterized by microcephaly, chromosomal instability, immunodeficiency, and predisposition to malignancy. This retrospective study, characterizing the clinical and immunological status of patients with NBS at time of diagnosis, was designed to assess whether any parameters were useful in disease prognosis, and could help determine patients qualified for hematopoietic stem cell transplantation.


The clinical and immunological characteristics of 149 NBS patients registered in the online database of the European Society for Immune Deficiencies were analyzed.


Of the 149 NBS patients, 91 (61 %), of median age 14.3 years, remained alive at the time of analysis. These patients were clinically heterogeneous, with variable immune defects, ranging from negligible to severe dysfunction. Humoral deficiencies predisposed NBS patients to recurrent/chronic respiratory tract infections and worsened long-term clinical prognosis. Eighty malignancies, most of lymphoid origin (especially non-Hodgkin’s lymphomas), were diagnosed in 42 % of patients, with malignancy being the leading cause of death in this cohort. Survival probabilities at 5, 10, 20 and 30 years of age were 95, 85, 50 and 35 %, respectively, and were significantly lower in patients with than without malignancies.


The extremely high incidence of malignancies, mostly non-Hodgkin’s lymphomas, was the main risk factor affecting survival probability in NBS patients. Because treatment of NBS is very difficult and frequently unsuccessful, the search for an alternative medical intervention such as hematopoietic stem cell transplantation is of great clinical importance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others


  1. Varon R, Seemanova E, Chrzanowska K, Hnateyko O, Piekutowska-Abramczuk D, Krajewska-Walasek M. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three slav populations. Eur J Hum Genet. 2000;8:900–2.

    Article  CAS  Google Scholar 

  2. Weemaes CM, Hustinx TW, Scheres JM, van Munster PJ, Bakkeren JA, Taalman RD. A new chromosomal instability disorder: the Nijmegen breakage syndrome. Acta Paediatr Scand. 1981;70:557–64.

    Article  CAS  Google Scholar 

  3. Varon R, Vissinga C, Platzer M, et al. Nibrin, a novel DNA doublestrand break protein, is mutated in Nijmegen breakage syndrome. Cell. 1998;93:467–76.

    Article  CAS  Google Scholar 

  4. The International Nijmegen Breakage Syndrome Study Group. Nijmegen breakage syndrome. Arch Dis Child. 2000;82:400–6.

    Article  Google Scholar 

  5. Gregorek H, Chrzanowska KH, Dzierzanowska-Fangrat K, Wakulińska A, Pietrucha B, Zapaśnik A, et al. Nijmegen breakage syndrome: long-term monitoring of viral and immunological biomarkers in peripheral blood before development of malignancy. Clin Immunol. 2010;135:440–7.

    Article  CAS  Google Scholar 

  6. NBS diagnostic criteria. Diagnostic criteria for PID. ESID society website. Available at : Accessed February 1, 2006.

  7. Wolska-Kuśnierz B, Gregorek H, Zapaśnik A, Syczewska M, Klaudel-Dreszler M, Pietrucha B, et al. Reference values for serum immunoglobulins G, A, M i D in children and adults, inhabitants of Mazovia district. Standardy Med. 2010;7:524–32.

    Google Scholar 

  8. Gregorek H, Imielska D, Gornicki J, Mikołajewicz J, Przeradzka B, Madaliński K. Development of IgG subclasses in healthy Polish children. Arch Immunol Ther Exp. 1994;42:377–82.

    CAS  Google Scholar 

  9. Piatosa B, Wolska-Kusnierz B, Siewiera K, Grzduk H, Gałkowska E, Bernatowska E. Distribution of leukocyte and lymphocyte subsets in peripheral blood. Age related normal values for preliminary evaluation of the immune status in Polish children. Cent Eur J Immunol. 2010;35:168–75.

    Google Scholar 

  10. Gregorek H, Chrzanowska KH, Michałkiewicz J, Syczewska M, Madaliński K. Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: an 8-year follow-up study in a single centre. Clin Exp Immunol. 2002;130:319–24.

    Article  CAS  Google Scholar 

  11. Piatosa B, van der Burg M, Siewiera K, Pac M, van Dongen JM, Langerak AW, et al. The defect in humoral immunity in patients with Nijmegen breakage syndrome is partly explained by defects in peripheral B lymphocyte maturation. Cytometry. 2012;81:835–42.

    Article  Google Scholar 

  12. Yeo TC, Xia D, Hassouneh S, Yang XO, Sabath DE, Sperling K, et al. V(D)J rearrangement in Nijmegen breakage syndrome. Mol Immunol. 2000;37:1131–9.

    Article  CAS  Google Scholar 

  13. Michałkiewicz J, Barth C, Chrzanowska K, Gregorek H, Syczewska M, Weemaes CMB, et al. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome. Clin Exp Immunol. 2003;134:482–90.

    Article  Google Scholar 

  14. Resnick IB, Kondratenko I, Togoev O, Vasserman N, Shagina I, Evgrafov O, et al. Nijmegen breakage syndrome: clinical characteristics and mutation analysis in eight unrelated Russian families. J Pediatr. 2002;140:355–61.

    Article  Google Scholar 

  15. Erdös M, Tóth B, Veres I, Kiss M, Remenyik E, Maródi L. Nijmegen breakage syndrome complicated with primary cutaneous tuberculosis. Pediatr Infect Dis J. 2011;30:359–60.

    Article  Google Scholar 

  16. Krysztopa-Grzybowska K, Brzezińska S, Augustynowicz-Kopeć E, et al. Descendant of daughter Brazilian BCG Moreau substrain in Poland. Vaccine. 2012;30:5512–8.

    Article  Google Scholar 

  17. Bernatowska E, Wolska–Kusnierz B, Pac M, et al. Disseminated bacillus calmette-guerin infection and immunodeficiency. Emerg Infect Dis. 2007;5:179–801.

    Google Scholar 

  18. Wakulinska A. Assessment of diagnosis and therapy of lymphoma in patients with Nijmegen Breakage Syndrome (PhD dissertation). Children’s Memorial Health Institute, Warsaw; 2010:1–161. Accessed December 6, 2010.

  19. Seidemann K, Henze G, Beck JD, Sauerbrey A, Kühl J, Mann G, et al. Non Hodgkin’s lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials. Ann Oncol. 2000;11:141–5.

    Article  Google Scholar 

  20. Szczepaniak-Kubat A, Trelińska J, Zalewska-Szewczyk B, et al. Inwazyjne zakażenie grzybicze w przebiegu chemioterapii u pacjentów z zespołem Nijmegen - prezentacja dwóch przypadków. Przeg Pediatr. 2007;37:331–4.

    Google Scholar 

  21. Gregorek H, Zapaśnik A, Chrzanowska K, Kasztelewicz B, Pietrucha B, Heropolitańska-Pliszka E, et al. Viral infections and analysis of circulating immune complexes in patients with Nijmegen breakage syndrome, a cancer-prone disease with profound immunodeficiency. Clin Microbiol Infect. 2011;17:413–4.

    Google Scholar 

  22. Krüger L, Demuth I, Neitzel H, Varon R, Sperling K, Chrzanowska KH, et al. Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein. Carcinogenesis. 2007;28:107–11.

    Article  Google Scholar 

  23. Kałwak K, Wolska-Kuśnierz B, Piatosa B. Nijmegen breakage syndrome, diagnosis and management, role of SCT. Onkologie (Czech Republic) 2011; Suppl R.5; 23–25.

  24. New HV, Cale CM, Tischkowitz M, Jones A, Telfer P, Veys P, et al. Nijmegen breakage syndrome diagnosed as Fanconi anaemia. Pediatr Blood Cancer. 2005;44:494–9.

    Article  Google Scholar 

  25. Gennery AR, Slatter MA, Bhattacharya A, Jeggo PA, Abinun M, Flood TJ, et al. Bone marrow transplantation for Nijmegen breakage syndrome. J Pediatr Hematol Oncol. 2005;27:239.

    Article  Google Scholar 

  26. Albert MH, Gennery AR, Greil J, Cale CM, Kalwak K, Kondratenko I, et al. Successful SCT for Nijmegen breakage syndrome. Bone Marrow Transplant. 2010;45:622–6.

    Article  CAS  Google Scholar 

  27. Ussowicz M, Musiał J, Duszeńko E, Haus O, Kałwak K. Long term survival after allogeneic- matched sibling PBSC transplantation with conditioning consisting of low-dose busilvex and fludarabine in a 3-year- old boy with ataxia-telangiectasia syndrome and ALL. Bone Marrow Transplant. 2013;48:740–1.

    Article  CAS  Google Scholar 

  28. Patel JP, Puck JM, Srinivasan R, Brown C, Sunderam U, Kundu K, et al. Nijmegen breakage syndrome detected by newborn screening for T cell receptor excision circles (TRECs). J Clin Immunol. 2015;35:227–33.

    Article  CAS  Google Scholar 

Download references


This work was supported in part by grant N N407 1714 34 from the Polish Ministry of Science and Higher Education and by internal grant no. S123/2012 funded by the CMHI, Warsaw, Poland.

Conflict of Interests

Urszula Skarżyńska was supported by EURO-GENE-SCAN 223293 grant, Benjamin Gathmann has served as an ESID Online Database Coordinator, which is supported by industry. The remaining authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations



Corresponding author

Correspondence to Beata Wolska-Kuśnierz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wolska-Kuśnierz, B., Gregorek, H., Chrzanowska, K. et al. Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options – a Retrospective Analysis. J Clin Immunol 35, 538–549 (2015).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: